NYXOID® nasal spray

NYXOID® is not a substitute for emergency medical care1. Call 000 immediately before administering naloxone1. Additional doses may be required until emergency medical treatment arrives1. Ask your pharmacist at the time of purchase.
Ask your pharmacist - they must decide if this product is right for you

About NYXOID® nasal spray

NYXOID® is intended as part of the emergency treatment for known or suspected opioid overdose1.

Opioids include substances such as: buprenorphine, codeine, fentanyl, heroin, methadone, morphine oxycodone2.

 

Each pack contains 2 nasal sprays (2 single-dose units). 

 

If an overdose is suspected, call 000 for medical assistance before administering NYXOID®

 

NYXOID® nasal spray should be carried by anyone at risk of overdosing on an opioid, or witnessing an opioid overdose.1 Carers such as close family or friends should know where to find NYXOID® in case of emergency.

 

What is naloxone? 

NYXOID® nasal spray contains naloxone, which temporarily reverses the effect of opioid drugs.1 Naloxone works by displacing opioid molecules from their receptors in the body and brain1. 

From 1 July 2022, naloxone is free with no prescription via the Take Home Naloxone (THN) Program nationwide. This is for anyone who may experience or witness, an opioid overdose or adverse reaction. More information about the THN program can be found here.

 

Reference: 1. NYXOID® Nasal Spray Consumer Product Information, December 2020. 2. NYXOID® Nasal Spray Medicine Information, 4 December 2020. 3. Alcohol and Drug Foundation. Opioids. Sep 2026. Available at: https://adf.org.au/drug-facts/opioids/ 4. Australian Government Department of Health, Disability and Ageing.